Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Sickle cell pain: Opioids appear safe for inpatients

Akinboro OA et al. ASH 2018, Abstract 315

Publish date:: December 24, 2018

Key clinical point: Sickle cell disease patients appear to be at lower risk for opioid-related mortality than the general U.S. population.

Major finding: While the rate of inpatient death from opioid overdose rose 350% among the general U.S. population from 1998 to 2013, it remained essentially at zero among patients with sickle cell disease.

Study details: A retrospective analysis of discharge diagnoses from the National Inpatient Sample from 1998 to 2013.

Disclosures: The researchers reported having no relevant financial disclosures.

Read the article here.

Citation:

Akinboro OA et al. ASH 2018, Abstract 315.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

PDAC: Tumor reduction after neoadjuvant therapy may predict postsurgical survival,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

‘Impressive’ local control with MRI-guided brachytherapy in cervical cancer,

U.S. mothers underestimate role breastfeeding plays in curbing breast cancer,

Must Reads in Anemia

Emotions, worse attention linked to pain-related health care use SCD,

Oxidatative stress-related genetic variant tied to stroke risk in sickle cell patients,

Genetic variants may predict stroke in some adult SCD populations,

Severe COVID-19 may lower hemoglobin levels,

Low plasma sodium levels can predict complications in acute painful episodes of SCD,